Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma
Liang Zhao, Yizhen Pang, Hua Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 11, pp. 3606-3617
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1557-1569
Open Access | Times Cited: 112
Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
Mengting Li, Muhsin H. Younis, Yongxue Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2844-2868
Open Access | Times Cited: 74
FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
Rong Huang, Yu Pu, Shun Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using68Ga-FAP-2286: Comparison with18F-FDG and68Ga-FAPI-46 in a Single-Center, Prospective Study
Yizhen Pang, Liang Zhao, Tinghua Meng, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 3, pp. 386-394
Open Access | Times Cited: 53
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
Laura Gilardi, Lighea Simona Airò Farulla, Emre Demirci, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 523-523
Open Access | Times Cited: 52
Design, Preclinical Evaluation, and Clinical Translation of68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma
Liang Zhao, Yizhen Pang, Jianyang Fang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 394-401
Open Access | Times Cited: 9
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 8
Long-term survival with pemetrexed-based chemotherapy in a patient with metastatic lung adenocarcinoma of unclear primary origin harboring MTHFR C677T(T/T) mutation: a case report
Yuan Yu, Nanjing Li, Jin Wang
Frontiers in Oncology (2025) Vol. 14
Open Access
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review
Giorgio Treglia, Barbara Muoio, Hessamoddin Roustaei, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11192-11192
Open Access | Times Cited: 43
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
Junhao Wu, Hao Deng, Haoshu Zhong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3863-3863
Open Access | Times Cited: 16
The performance of 68Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET/CT
Yaqun Jiang, Bing Wen, Chongjiao Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 2114-2126
Closed Access | Times Cited: 16
Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Hessamoddin Roustaei, Zahra Kiamanesh, Emran Askari, et al.
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 25
Current research topics in FAPI theranostics: a bibliometric analysis
Andor F. van den Hoven, Ruth G.M. Keijsers, Marnix G. E. H. Lam, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1014-1027
Closed Access | Times Cited: 25
Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis
Grayson Wass, Kari Clifford, Rathan M. Subramaniam
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 8, pp. 1218-1224
Open Access | Times Cited: 12
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
Zeyu Zhang, Jinxin Tao, Jiangdong Qiu, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 361-381
Closed Access | Times Cited: 11
Role of 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications
Carmelo Caldarella, Marina De Risi, Mariangela Massaccesi, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1905-1905
Open Access | Times Cited: 4
Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
Serkan Kuyumcu, Yasemin Şanlı, Rathan M. Subramaniam
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30
Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge
Zhouying Peng, Yumin Wang, Ruohao Fan, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4111-4111
Open Access | Times Cited: 18
An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy
Mengxin Xu, Junyi Chen, Pu Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3214-3224
Closed Access | Times Cited: 10
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
Laura Gilardi, Lighea Simona Airò Farulla, Emre Demirci, et al.
(2022)
Open Access | Times Cited: 17
Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma
Liang Zhao, Yizhen Pang, Shanyu Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 593-601
Closed Access | Times Cited: 16
Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology
Rathan M. Subramaniam
PET Clinics (2024) Vol. 19, Iss. 2, pp. 125-129
Closed Access | Times Cited: 2
PET/CT FAPI: Procedure and evidence review in oncology
A.P. Caresia-Aróztegui, Jazmin Rosales, M. Rodríguez Fraile, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2024) Vol. 43, Iss. 2, pp. 130-140
Closed Access | Times Cited: 2
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study
Jieling Zheng, Guochang Wang, Ru Qian, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3386-3399
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top